UniQure is breathing a sigh of relief after its controversial gene therapy for Huntington’s disease successfully cleared a critical regulatory hurdle. The company has...
Swiss banking giant UBS has downgraded its outlook on the Spanish construction firm Ferrovial, shifting the stock from a buy to neutral following the...
Broadcom shares took a dip during recent trading sessions despite reporting fiscal third quarter results that managed to beat analyst expectations across several key...
Wall Street appears to be catching its breath after a volatile stretch, with stock futures remaining largely flat Wednesday evening. This quiet period follows...